Advertisement

HindustanTimes Wed,30 Jul 2014

Novartis India says will continue to file for patents

Reuters  Mumbai, April 01, 2013
First Published: 15:22 IST(1/4/2013) | Last Updated: 15:23 IST(1/4/2013)

Novartis India Ltd, a unit of Swiss drugmaker Novartis AG, will continue to file for patents in India, its vice chairman said on Monday, after the the Supreme Court rejected its plea for patent protection of its drug Glivec.

Advertisement

Novartis India will also continue to invest there, but with caution, Ranjit Shahani, who is also the managing director of the company, told reporters after the Supreme Court judgment.

Earlier on Monday, the court dismissed Novartis' petition seeking patent protection for cancer drug Glivec, a serious blow to Western pharmaceutical firms who are increasingly focusing on India to drive sales.


Advertisement
more from Business

Amazon to invest $2 bn more in India, after Flipkart announces $1 bn fresh funding

Amazon.com Inc will invest an added $2 billion in India as the e-commerce giant ramps up business in the country, the company said on Wednesday, a day after local rival Flipkart announced a fresh round of funding worth $1 billion.
markets
Advertisement
Most Popular
Advertisement
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved